[Purification and identification of mRNA of immune (gamma) interferon from human splenocytes]. 1983

L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ

The isolation of total RNA from primary culture of human splenocytes and its physico-chemical and biological properties are described. Human splenocytes are characterized by a high content of mRNA of human immune interferon, low content of total RNA and an extremely high activity of RNAases. Therefore it was necessary to elaborate conditions for the isolation of mRNA without DNA contaminants in the presence of extensive inhibitors of the RNAase activity. These include cell homogenization, separation of cytoplasm at -10 degrees C and treatment by RNAase inhibitors--ribonucleoside-vanadyl complexes or a combination of aurin-tricarboxylic acid with dithiothreitol. The resulting preparations of total RNA were purified by chromatography on oligo (dT)-cellulose and translated in a cell-free system from rabbit reticulocytes. These preparations were free of nonspecific translation inhibitors which are normally present in the lymphoid cells mRNA. In a cell-free system mRNA of human splenocytes induced with staphylococcal enterotoxin A code the synthesis of biologically active interferon which was identified as immune (gamma) human interferon, using a serological analysis. The preparations of immune interferon mRNA obtained under the conditions described above can further be used for cloning of the corresponding gene in bacterial cells.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012260 Ribonucleases Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-. Nucleases, RNA,RNase,Acid Ribonuclease,Alkaline Ribonuclease,Ribonuclease,RNA Nucleases,Ribonuclease, Acid,Ribonuclease, Alkaline
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations

Related Publications

L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
March 1981, Proceedings of the National Academy of Sciences of the United States of America,
L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
June 1981, Proceedings of the National Academy of Sciences of the United States of America,
L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
March 1982, Proceedings of the National Academy of Sciences of the United States of America,
L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
January 1982, Journal of interferon research,
L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
January 1981, Texas reports on biology and medicine,
L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
July 1988, Proceedings of the National Academy of Sciences of the United States of America,
L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
January 1981, Methods in enzymology,
L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
January 1986, Methods in enzymology,
L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
November 1985, Biochemical and biophysical research communications,
L A Liakh, and S N Khil'ko, and R D Aspetov, and D N Nosik, and A S Novokhatskiĭ
September 1996, Proteins,
Copied contents to your clipboard!